Literature DB >> 22165582

The effects of reduction operation with genital lymphedema on the frequency of erysipelas and the quality of life.

M Zvonik1, E Földi, G Felmerer.   

Abstract

Genital lymphedema represents a severe disability for patients particularly when complicated by erysipelas, the most frequent complication. The objectives of this study were: to investigate the frequency of erysipelas in patients with genital lymphedema and genital lymphatic cysts who underwent evaluation for surgical treatment, to observe the influence of resection operations on the frequency of erysipelas, and to measure changes in the quality of life due to the resection. A total of 93 patients with genital lymphedema were studied. All patients underwent integrated care treatment in the Földi Clinic, Hinterzarten and the Department of Plastic and Hand Surgery of the University Hospital Freiburg during the period between 1997 and 2007. 44 of these patients underwent surgical treatment of genital lymphedema. The results indicate that lymphatic cysts were the most important risk-aggravating factor for recurrent erysipelas with lymphorrhea in the genital region (p < 0.001). Following the resection operation, however, the number of erysipelas incidents significantly decreased (p < 0.001). In addition, the antibiotic dose could be reduced after surgery (p = 0.039) and an improved quality of life was achieved (p < 0.001).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22165582

Source DB:  PubMed          Journal:  Lymphology        ISSN: 0024-7766            Impact factor:   1.286


  2 in total

1.  Laser CO2 treatment for vulvar lymphedema secondary to gynecological cancer therapy: A report of two cases and review of the literature.

Authors:  Francesco Sopracordevole; Francesca Mancioli; Vincenzo Canzonieri; Monica Buttignol; Giorgio Giorda; Andrea Ciavattini
Journal:  Oncol Lett       Date:  2015-02-12       Impact factor: 2.967

2.  Cellulitis in aged persons: a neglected infection in the literature.

Authors:  Anis Mzabi; Wafa Marrakchi; Zeineb Alaya; Fatma Ben Fredj; Amel Rezgui; Elyès Bouajina; Chedia Laouani Kechrid
Journal:  Pan Afr Med J       Date:  2017-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.